Faecalibacterium prausnitzii EXL01 for the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Crohn’s Disease: a first in human trial

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-026-72375-y
Affiliations:
7
Authors:
14
Go to article
Institutions Authors Share
Exeliom Biosciences, France
4.000000
 0.29
Gut, Liver and Microbiome Research (FHU GLIMMER), France
3.333333
 0.24
Saint Antoine Research Center (CRSA), France
2.333333
 0.17
Micalis Institute, France
1.333333
 0.10
University Hospital of Liege, Belgium
1.000000
 0.07
Parean Biotechnologies, France
1.000000
 0.07
Amsterdam UMC, Netherlands
1.000000
 0.07
Interested in Agricultural Biotechnology?